RDILAB operates under strict regulatory compliance standards, ensuring the highest level of quality, safety, and traceability across all analytical activities.

The company is officially authorised and inspected by INFARMED, I.P. for compliance with Good Manufacturing Practices (GMP) applicable to medicinal products for human use. This certification confirms RDILAB’s adherence to European GMP requirements, ensuring that all processes, documentation, and quality systems meet the regulatory standards required for pharmaceutical applications.

In addition, RDILAB is also certified by the Directorate-General for Food and Veterinary (DGAV) for activities related to veterinary medicinal products, ensuring full compliance with applicable veterinary GMP regulations.

RDILAB further holds the necessary authorisation for activities involving medical cannabis, operating under the relevant national licensing framework. This license enables the company to support analytical testing and quality control activities within the cannabis supply chain, in accordance with applicable regulatory requirements.

Together, these authorisations reflect RDILAB’s commitment to regulatory excellence and its capability to support clients operating in highly regulated pharmaceutical, veterinary, and controlled product sectors.